BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 11, 2005
View Archived Issues
American Bioscience Gains FDA Approval For Abraxane
Providing new hope for breast cancer patients, Abraxane soon will offer the antitumor benefits, without the toxic solvent side effects, of paclitaxel. (BioWorld Today)
Read More
Sanofi-Aventis Paying $50M To Regeneron In VEGF Deal
Read More
Saving Cash, Refocusing, Isis Cuts Work Force By 40 Percent
Read More
Invitrogen Getting Antibodies Via $60M Purchase Of Zymed
Read More
Antisoma Buying Aptamera In £11.5M All-Share Merger
Read More
Other News To Note
Read More
Appointments And Advancements
Read More